Recognizing and Treating Neuromodulation Device Infections Early: The DETER Recommendations

Recognizing and Treating Neuromodulation Device Infections Early: The DETER Recommendations

By Ivan Urits, MD – Board Certified in Anesthesiology and Pain Medicine

Published February 24, 2026 | Category: Pain Medicine

Infection is one of the most serious complications of implanted pain devices such as spinal cord stimulators (SCS) and intrathecal pumps. It can range from a superficial wound problem to a deep infection, sepsis, meningitis or nerve injury. In 2025, a large multidisciplinary group published the Device Evaluation, Treatment, and Explantation Recommendations (DETER) in the Journal of Pain Research.

This summary is based on the published abstract. Read the abstract on PubMed

What the authors did

A group of 33 pain physicians, infectious disease specialists and other experts reviewed the evidence and practice experience on neuromodulation device infections. They wrote best practices covering diagnosis, treatment, device removal and possible reimplantation.

Key recommendations

  • Education first: Patients and clinicians should know how to care for the wound and which signs of infection or sepsis need immediate attention.
  • Match treatment to severity: Antibiotic choice and duration depend on whether the infection is superficial or deep.
  • Deep infections usually mean device removal. Diagnosis should be made quickly with imaging such as MRI or CT, followed by explant and culture-guided antibiotics, often with infectious disease and spine surgery input.
  • Aggressive early treatment has improved the chance of saving some devices.
  • Pump infections need extra planning: They carry a risk of meningitis, and sudden pump removal can cause medication withdrawal that must be managed.
  • Cultures may be negative if antibiotics were started first, so lab trends can help track response.
  • After surgery: Use standardized protocols, patient education, close follow-up and active surveillance to catch infections early.

Why this matters

Delays in recognizing a device infection can turn a treatable wound problem into an epidural abscess or sepsis. Clear, shared steps help patients, primary care doctors, emergency physicians and implanting teams act quickly and consistently.

Limitations

These are expert best practices drawn from a limited evidence base, much of it observational. Local resources and patient factors will shape how each recommendation is applied.

Safety takeaways: how to apply it

For pain physicians and procedure teams

  • Give every implant patient written wound-care instructions and a clear list of warning signs, with a number to call.
  • Have a low threshold for imaging when a deep infection is possible.
  • Involve infectious disease and spine surgery early for deep infections, and plan for withdrawal if an intrathecal pump must be removed.

For hospitals, clinics and safety leaders

  • Create an infection pathway for implanted devices and track infections and explants.

For patients and families

  • Watch the incisions for redness, swelling, drainage or opening, and report fever, chills or worsening back pain right away.

Reference

  1. Pritzlaff SG, Goree JH, Dare RK, D'Souza RS, Lee DW, Dudas AA, et al. Device Evaluation, Treatment, and Explantation Recommendations (DETER): Review and Best Practices for Managing Neuromodulation Device Infections. J Pain Res. 2025;18:2147-2161. doi:10.2147/JPR.S509623. PMID: 40297490. PubMed: https://pubmed.ncbi.nlm.nih.gov/40297490/

This article is educational information, not legal or medical advice.

Previous
Previous

Key Safety Rules for Epidural and Sacroiliac Joint Injections

Next
Next

Broader MRI Labeling Helped More Stimulator Patients Get Scans Within Safety Conditions